Protective Effect of Purple Sweet Potato (Ipomoea batatas Linn, Convolvulaceae) on Neuroinflammatory Responses in Lipopolysaccharide-Stimulated Microglial Cells
Purpose: To evaluate the protective effects of purple sweet potato (Ipomoea batatas Linn, Convolvulaceae) extract (IBE) in stimulated BV-2 microglial cells and its anti-oxidant properties.
Methods: Cell viability assessment was performed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide (MTT) assay. Lipopolysaccharide (LPS) was used to activate BV-2 microglia. Nitric oxide (NO) levels were measured using Griess assay. Inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 expressional levels were measured by Western blot analysis. Tumor necrosis factor-alpha (TNF-α) production was evaluated by enzyme-linked immunosorbent assay (ELISA). Antioxidant
properties were evaluated by 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging assay.
Results: LPS-activated excessive release of NO in BV-2 cells was significantly inhibited by IBE (p<0.001 at 100 µg/mL). Increased production of inflammatory mediators such as iNOS, COX-2 and TNF-α (p < 0.01 and p < 0.001 at 100 and 200 µg/ml, respectively) was attenuated by IBE concentration-dependently. IBE also scavenged DPPH radicals in a dose-dependent manner (p < 0.05 at 10 ìg/ml and p < 0.001 at 20 - 200 µg/ml).
Conclusion: These results indicate that IBE attenuated neuroinflammatory responses in LPS-activated BV-2 microglia by inhibiting excessive production of pro-inflammatory mediators such as NO, iNOS, COX-2 and TNF-α. The anti-neuroinflammatory potential of IBE may be related to its strong antioxidant properties.
Keywords: Ipomoea batatas, DPPH radicals, Anti-oxidant, Neuroinflammation, BV-2 microglia, Nitric oxide.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.